These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8491226)

  • 1. A simple two-strip method to determine the radiochemical purity of technetium-99m mercaptoacetyltriglycine.
    Chen F; Decristoforo C; Rohrbacher B; Riccabona G
    Eur J Nucl Med; 1993 Apr; 20(4):334-8. PubMed ID: 8491226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality control of instant kit 99mTc-mercapto acetyl triglycine with inter- and intra-operator measurements.
    Bozkurt MF; Kiratli PO; Konyali D; Metin F
    Hell J Nucl Med; 2009; 12(1):59-62. PubMed ID: 19330186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transferability of a two-strip method for the quality control of technetium-99m mercaptoacetyltriglycine ([
    Tessaire T; De Neef L; Cailly T; Peyronnet D; Vigne J
    Eur J Hosp Pharm; 2023 May; 30(3):167-171. PubMed ID: 34285112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An investigation of factors that might influence the radiochemical purity and stability of 99mTc-MAG3.
    Millar AM; O'Brien LM
    Eur J Nucl Med; 1990; 16(8-10):615-9. PubMed ID: 2143474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kit preparation of technetium-99m-mercaptoacetyltriglycine: analysis, biodistribution and comparison with technetium-99m-DTPA in patients with impaired renal function.
    Bannister KM; Penglis S; Bellen JC; Baker RJ; Chatterton BE
    J Nucl Med; 1990 Sep; 31(9):1568-73. PubMed ID: 2144317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of technetium-99m MAG3 kit with HPLC-purified technetium-99m MAG3 and OIH in rats.
    Coveney JR; Robbins MS
    J Nucl Med; 1987 Dec; 28(12):1881-7. PubMed ID: 2960790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new two-strip TLC method for the quality control of technetium-99m mercaptoacetyl-triglycine (
    Straub M; Leresche M; Pilloud C; Devynck F; Stritt N; Hesselmann R
    EJNMMI Radiopharm Chem; 2018; 3(1):5. PubMed ID: 29577070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the hepatobiliary excretion of technetium-99m-MAG3 and reconstitution factors affecting radiochemical purity.
    Shattuck LA; Eshima D; Taylor AT; Anderson TL; Graham DL; Latino FA; Payne SE
    J Nucl Med; 1994 Feb; 35(2):349-55. PubMed ID: 8295009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 99Tcm-MAG3: problems with radiochemical purity testing.
    Murray T; McKellar K; Owens J; Watson WS; Hilditch TE; Elliott AT
    Nucl Med Commun; 2000 Jan; 21(1):71-5. PubMed ID: 10717905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A better method of quality control for 99mTc-tetrofosmin.
    Hammes R; Joas LA; Kirschling TE; Ledford JR; Knox TL; Nybo MR; Sterzinger JJ
    J Nucl Med Technol; 2004 Jun; 32(2):72-8. PubMed ID: 15175403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of 99mTc-MAG3: radiochemical purity is affected by the residence time of sodium chloride injection in a three-part syringe.
    Waight CC; Beattie LA; O'Brien LM; Millar AM
    Nucl Med Commun; 2006 Feb; 27(2):197-200. PubMed ID: 16404235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality control of commercial 99mTc-human albumin kits.
    Müller T
    Eur J Nucl Med; 1985; 10(11-12):551-3. PubMed ID: 4029213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simplified method for determining the radiochemical purity of 99mTc-MAG3.
    Seetharaman S; Ballinger JR; Sosabowski MH
    J Nucl Med Technol; 2006 Sep; 34(3):179-83. PubMed ID: 16951288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical comparison of I-131 orthoiodohippurate and the kit formulation of Tc-99m mercaptoacetyltriglycine.
    Taylor A; Ziffer JA; Steves A; Eshima D; Delaney VB; Welchel JD
    Radiology; 1989 Mar; 170(3 Pt 1):721-5. PubMed ID: 2521734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of technetium-99m-L,L-EC in renal transplant recipients: a comparative study with technetium-99m-MAG3 and iodine-125-OIH.
    Stoffel M; Jamar F; Van Nerom C; Verbruggen A; Mourad M; Leners N; Squifflet JP; Beckers C
    J Nucl Med; 1994 Dec; 35(12):1951-8. PubMed ID: 7989976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technetium-99m labeled renal function and imaging agents: III. Synthesis of 99mTc-MAG3 and biodistribution of by-products.
    Brandau W; Bubeck B; Eisenhut M; Taylor DM
    Int J Rad Appl Instrum A; 1988; 39(2):121-9. PubMed ID: 2833469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Miniaturized Radiochemical Purity Testing for
    Fuente A; Zanca R; Boni R; Cataldi AG; Sollini M; Lazzeri E; Mariani G; Erba PA
    J Nucl Med Technol; 2017 Sep; 45(3):236-240. PubMed ID: 28705928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of quality control to detect errors in the preparation of technetium-99m disofenin (DISIDA).
    Lecklitner ML; Benedetto AR; Straw JD
    Clin Nucl Med; 1985 Jul; 10(7):468-74. PubMed ID: 4028598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of the radiochemical purity of (99m) Tc medronate injection by thin layer chromatography on iTLC-SG: effect of medronate concentration on the value measured.
    Cunnane CM; O'Brien LM; Waight LA; Millar AM
    J Labelled Comp Radiopharm; 2013 May; 56(5):301-4. PubMed ID: 24285375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of generator eluate age on the radiochemical purity of fractionated 99Tcm-MAG3.
    Hung JC; Thorson LM
    Nucl Med Commun; 1995 Mar; 16(3):157-60. PubMed ID: 7770239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.